Compare Novartis AG (NVS) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs US Bancorp — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while US Bancorp trades at $63.14 (market cap $98.36B). The key difference: Novartis AG is far larger — about 3× US Bancorp's market cap, and US Bancorp pays the higher dividend (3.29%). Which is the better fit depends on your goals.
| NVS | USB | |
|---|---|---|
Market Cap | $290.25B | $98.36B |
Sector | Health | Financials |
52-Week High | $168.62 | $64.01 |
52-Week Low | $113.50 | $43.94 |
Enterprise Value | $330.27B | — |
Dividend Yield | 3.17% | 3.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
